Encompass Health Corporation $EHC Shares Purchased by Jennison Associates LLC

Jennison Associates LLC boosted its position in shares of Encompass Health Corporation (NYSE:EHC) by 12.8% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 894,511 shares of the company’s stock after acquiring an additional 101,274 shares during the quarter. Jennison Associates LLC owned about 0.89% of Encompass Health worth $113,621,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Select Asset Management & Trust lifted its holdings in shares of Encompass Health by 67.7% during the third quarter. Select Asset Management & Trust now owns 12,387 shares of the company’s stock worth $1,573,000 after purchasing an additional 5,000 shares during the period. iA Global Asset Management Inc. lifted its stake in Encompass Health by 9.1% during the 3rd quarter. iA Global Asset Management Inc. now owns 65,281 shares of the company’s stock valued at $8,292,000 after acquiring an additional 5,440 shares during the period. Inscription Capital LLC lifted its stake in Encompass Health by 47.8% during the 3rd quarter. Inscription Capital LLC now owns 3,363 shares of the company’s stock valued at $427,000 after acquiring an additional 1,088 shares during the period. Root Financial Partners LLC purchased a new stake in shares of Encompass Health in the 3rd quarter valued at $39,000. Finally, Arkadios Wealth Advisors increased its stake in shares of Encompass Health by 26.4% in the third quarter. Arkadios Wealth Advisors now owns 11,098 shares of the company’s stock worth $1,410,000 after acquiring an additional 2,318 shares during the period. 97.25% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have commented on the stock. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Barclays boosted their price objective on Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. UBS Group boosted their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. Finally, Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a research note on Friday, October 31st. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Buy” and an average target price of $142.86.

Encompass Health Trading Down 1.0%

EHC stock opened at $98.36 on Friday. Encompass Health Corporation has a 12-month low of $92.53 and a 12-month high of $127.99. The business’s 50-day moving average is $107.79 and its 200 day moving average is $115.60. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76. The stock has a market cap of $9.90 billion, a price-to-earnings ratio of 18.59, a PEG ratio of 1.58 and a beta of 0.74.

Encompass Health (NYSE:EHC) last released its earnings results on Wednesday, October 29th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.04. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.The business had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.48 billion. During the same quarter last year, the business posted $1.03 earnings per share. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.